ArticleFrontiers in immunology2024

Corrigendum: Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing.

Michel Demeule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.